首页> 外文期刊>Chembiochem: A European journal of chemical biology >Addressing the Challenge of Changing the Specificity of RNase T1 with Rational and Evolutionary Approaches
【24h】

Addressing the Challenge of Changing the Specificity of RNase T1 with Rational and Evolutionary Approaches

机译:用合理和进化的方法应对改变RNase T1特异性的挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Although ribonuclease T1 (RNase T1) is one of the best-characterized proteins with respect to structure and enzymatic action, numerous attempts at altering the specificity of the enzyme to cleave single-stranded RNA at the 3'-side of adenylic instead of guanylic residues by rational approaches have failed so far. Recently we generated and characterized the RNase T1 variant RV with a 7200-fold increase in adenylyl-3',5'-cytidine (ApC)/guanylyl-3',5'-cytidine (GpC) preference, with the guanine-binding loop changed from 41-KYNNYE-46 (wt) to 41-EFRNWN-46. Now we have introduced the asparagine residue at position 46 of the wild-type enzyme as a single-point mutation in variant E46N and in combination with the Y45W exchange also occurring in RV. Both variants show an improved ApC/GpC preference with a 1450-fold increase for E46N and a 2100-fold increase for Y45W/E46N in comparison to wild-type activity. We also addressed the challenge of altering enzyme specificity with an evolutionary approach. We have randomly introduced point mutations into the RNase T1 wild-type gene and into the gene of the variant RV with different mutation rates. Altogether we have screened about 100 000 individual clones for activity on RNase indicator plates; 533 of these clones were active. A significant change in substrate specificity towards an ApC preference could not be observed for any of these active variants; this demonstrated the magnitude of the challenge to alter the specificity of this evolutionary perfected enzyme.
机译:尽管就结构和酶促作用而言,核糖核酸酶T1(RNase T1)是最表征的蛋白质之一,但人们进行了许多尝试来改变酶的特异性,以在腺苷酸而不是鸟苷酸残基的3'侧切割单链RNA。迄今为止,通过理性方法失败了。最近,我们生成并表征了带有腺嘌呤结合环的腺苷基3',5'-胞苷(ApC)/鸟苷基3',5'-胞苷(GpC)偏好增加7200倍的RNase T1变体RV。从41-KYNNYE-46(wt)更改为41-EFRNWN-46。现在,我们在野生型酶的46位处引入了天冬酰胺残基,作为变体E46N中的单点突变,并与RV中也发生的Y45W交换结合。与野生型活性相比,两种变体均显示出改进的ApC / GpC偏好性,其中E46N的增加了1450倍,Y45W / E46N的增加了2100倍。我们还解决了用进化方法改变酶特异性的挑战。我们已将点突变随机引入RNase T1野生型基因和具有不同突变率的RV变异基因中。我们总共筛选了约10万个克隆,以检测其在RNase指示板上的活性。这些克隆中有533个处于活动状态。对于这些活性变体中的任何一个,均未观察到底物特异性朝ApC偏好的显着变化。这证明了改变这种进化完善的酶的特异性所面临的挑战的幅度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号